🇺🇸 FDA
Patent

US 9695116

Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives

granted A61PA61P25/24A61P3/04

Quick answer

US patent 9695116 (Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives) held by REVIVA PHARMACEUTICALS, INC. expires Mon Jun 29 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REVIVA PHARMACEUTICALS, INC.
Grant date
Tue Jul 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 29 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61P, A61P25/24, A61P3/04